Main Menu

Professor Alan Melcher

Group Leader

The alt text
Professor Melcher is a clinician scientist studying how to activate the immune system to recognise and attack cancer. In particular, he works on oncolytic, anti-cancer viruses, which work mainly as a type of immunotherapy, and is a specialist in melanoma and head and neck cancer. Group: Breast Cancer Immunology Group: Translational Immunotherapy
+44 20 7153 5205 ORCID 0000-0002-2042-3380


Professor Alan Melcher graduated in medicine from the University of Oxford in 1989, and trained in Clinical Oncology (Radiotherapy and Chemotherapy) in Cardiff, London and Leeds.

See all news stories on our website that feature the work of Professor Melcher and colleagues.

Read news

Following completion of his PhD at the Imperial Cancer Research Fund (now Cancer Research UK) in London, he was a post-doctoral research fellow at the Mayo Clinic, Minnesota, before returning to the UK, where he became Professor of Clinical Oncology and Biotherapy in Leeds in 2007.

In April 2016, he moved to The Institute of Cancer Research, London, as Professor of Translational Immunology and Honorary Consultant Oncologist at The Royal Marsden NHS Foundation Trust. He combines a clinical practice in head and neck cancer and melanoma with laboratory and translational research focused on oncolytic viruses and immunotherapy for the treatment of cancer.

Professor Melcher is the Lead of the Centre for Translational Immunotherapy, a virtual Centre  bringing together staff and students from the ICR and our partner hospital, the Royal Marsden, that aims to increase communication between clinicians and scientists with an interest in translational immunotherapy.

Centre for Translational Immunotherapy

Professor Melcher is also a member of the Cancer Research UK Convergence Science Centre, which brings together leading researchers in engineering, physical sciences, life sciences and medicine to develop innovative ways to address challenges in cancer.

Convergence Science Centre